In 2024, the global blood flow measurement devices market was valued at USD 584.02 million and it is expected to reach USD 1299.13 million by 2033 from USD 638.28 million in 2025, growing at a CAGR of 9.29 % during the forecast period.
Blood flow measurement devices are used to detect and measure blood flow among the body's different organs like veins and arteries. Blood flow provides the transportation of nutrients, hormones, oxygen to the entire body in maintaining cell metabolism and the body's temperature.There are constant blood flow volumes in the body that vary with the organ's vitality and needs. Some blood flow values are 100 to 250 cm/s in the aorta, the abdominal segment contains 100 cm/s blood flow, and the concave vein needs a continuous blood flow of about 5 to 10 cm/s. Blood acts as a food and nutritional support for various organs, and an adequate amount of blood is essential for their proper functioning. Besides, various diseases and disorders such as hypertension and diabetes can lead to a variation in blood supply to the organs, which, if left untreated, can lead to organ failure. Blood flow measurement can provide vital information that can be analyzed for accurate diagnosis of the diseases.
As the American Heart Association published it, an estimated 31% of the United States' deaths were happened due to heart-related issues in 2015. The aging population is another significant factor estimated to augment the global blood flow measurement devices market's growth. Increasing spending on healthcare is further predicted to boost the market growth. According to Disease Control and Prevention, the United States is spending nearly 3.2 trillion USD on healthcare expenditure for the people, and 90% of the amount is allotted to treat chronic and mental health disorders.The other factors that boost the growth of the blood flow measurement devices market are Increase in non-communicable diseases is also expected to stimulate market growth. Growing technological developments is also a driving factor for global blood flow measurement devices market growth.The increasing number of tech-advanced blood flow measurement device approvals is also expected to hike the market’s growth rate.Entering the unused market and developing clinical applications for blood flow meters is an opportunity for the blood flow measuring devices market. The worldwide market for blood flow meters is consolidated, with some key players have the most significant share due to active R & D activities. Players are developing innovative products to capitalize on lucrative opportunities in the blood flow measurement devices market.
The major restraint limiting the growth of the blood flow measurement devices market is developing alternative methods for the treatment of cardiovascular diseases.The high cost of the devices, strict government rules in developed nations, and the shortage of expert professionals, and unfavorable reimbursement policies are considered significant restraints to the global blood flow measurement devices market.
REPORT METRIC |
DETAILS |
Market Size Available |
2024 to 2033 |
Base Year |
2024 |
Forecast Period |
2025 to 2033 |
Segments Analysed |
By Product, Application, and Region |
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
Regions Analysed |
North America, Europe, Asia Pacific, Latin America, Middle East, and Africa |
Market Leaders Profiled |
Cook Medical, Inc., BIOPAC Systems, Inc., Atys Medical |
Based on the product, the ultrasound segment has contributed the largest share of the worldwide market for blood flow meters. In 2024, the Doppler ultrasonic segment had dominated the global ultrasound market leading to the growth of blood flow measurement devices and estimated to be growing at the same high pace during the forecast period.
Based on application, in 2023, cardiovascular disease has contributed to the significant share of revenues to the world market among the non-invasive applications. It is likely to maintain the trend during the forecast period.The CABG segment represented the largest share of the world market in 2023. The development of this segment can be attributed to a large number of CABG surgeries performed worldwide.
Presently, North America is leading the market by contributing the largest share of revenues in the given timeframe due to the geriatric population's growth and the prevalence of cardiovascular disease, the increased frequency of hypertension in the people, and increased funding. Likewise, technological advancements and the increasing number of organ transplants fuel the market for blood flow meters in North America.
The European is estimated to increase at a favorable rate from 2024 to 2029. This region is the second-largest market due to growing government assistance and enhanced healthcare infrastructure, together with an increasing need for minimally invasive treatment.
Over the next few years, the market is likely to witness the maximum growth rate in the Asia-Pacific region owing to the increasing pervasiveness of non-communicable diseases, the rise in the geriatric population, and the growing attention of industry players in the area. India and China are leading the market with quick enhancements in healthcare expenditure, new product launches, and growing demand for diagnostic services is to boost the market.
In terms of market share, Latin America is predicted to hike at a steady rate during the assessment period. Brazil is dominating Latin America and is estimated to continue the same trend during the forecast period.
The blood flow measurement devices market in the Middle East & Africa region is expected to have the least and moderate growth. UAE is leading the market due to the enhancement of the healthcare industry and the increasing availability of specialty care centers.
Some of the promising companies playing a leading role in the Global Blood Flow Measurement Devices Market profiled in the report are Cook Medical, Inc., BIOPAC Systems, Inc., Atys Medical, SONOTEC Ultraschallsensorik Halle GmbH, Moor Instruments Ltd., ADInstruments, Deltex Medical Group plc, Compumedics Ltd., Transonic Systems, Inc., Perimed AB, and Medistim ASA.
On May 31, 2017, Deltex Medical Group Plc announced its new patent that has received acceptance, a leader in Oesophageal Doppler Monitoring. The device filling covers the usage of Doppler measurements of blood flow, and that is measured using the oesophageal that is in co-occurrence with blood pressure signals. The Cardiac-ODM is used in patients during surgery to monitor and measure the blood flow. The ODM permits the doctors to step in quickly to do the changes in circulating blood volume.
On July 8, 2015, Compumedics Ltd. made a public statement that the brain blood-flow Doppler ultrasonography division, where the importance and impact can have business and trade and economic.
This research report on the global blood flow measurement devices market has been segmented and sub-segmented based on the product, application, and region.
By Product
By Application
By Region
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: sales@marketdataforecast.com
Reports By Region